跳至主要内容
临床试验/NCT04287465
NCT04287465进行中(未招募)不适用

Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode

Hospital District of Helsinki and Uusimaa1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
1
主要终点
The change of UPDRS III score

研究概览

简要总结

To compare the clinical outcome of patients with Parkinson's disease (PD) treated with directional deep brain (dDBS) stimulation undergoing subthalamic deep brain stimulation operation (STN-DBS) under general anesthesia versus local anesthesia.

详细描述

To compare the clinical outcome of patients with Parkinson's disease (PD) treated with directional deep brain (dDBS) stimulation undergoing subthalamic deep brain stimulation operation (STN-DBS) under general anesthesia versus local anesthesia.

In awake group, 10 patients with Parkinson's disease were treated with St Jude Medical/Abbott Infinity DBS system, and the electrode implantation and testing were performed while the patients were awake. In asleep group, 14 patients with Parkinson's disease were treated with St Jude Medical/Abbott Infinity DBS system, and the electrode implantation were performed while the patients were under general anesthesia. The clinical outcome of the DBS treatment, possible adverse effects and the electrode placement will be compared within these two groups.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Advanced Parkinson's disease
  • The clinical decision of DBS treatment
  • The clinical inclusion criteria of DBS treatment:
  • drug-resistant tremor
  • severe daily motor fluctuations or dyskinesia in despite of the optimal oral medication
  • an improvement of UPDRS III scores over 30 % in levodopa challenge test.

排除标准

  • The general exclusion criteria for DBS treatment:
  • a major depression
  • on-going psychosis
  • a significant brain atrophy observed in a brain MRI
  • a suspicion of atypical parkinsonism
  • marked cognitive decline.

结局指标

主要结局

The change of UPDRS III score

时间窗: 6 months

The UPDRS III score (0-60 points) at 6-months' follow-up compared to preoperative UPDRS III score

次要结局

  • Electrode trajectory(6 months)
  • The change of levodopa equivalent dose, LED(6 months)

研究者

发起方
Hospital District of Helsinki and Uusimaa
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maija Koivu

Principal Investigator

Hospital District of Helsinki and Uusimaa

研究点 (1)

Loading locations...

相似试验